Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R. White

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Clinical Pharmacokinetics|July 2, 2009
Characterization of the time course of carbamazepine deinduction by an enzyme turnover modelBaralee Punyawudho, James C Cloyd, Ilo E Leppik, et al.
European Urology Focus|February 18, 2026
Gut Microbiome as a Lifestyle Risk Factor Associated with Prostate CancerMichael A Liss, James R White, Molly Doris, et al.
Investigative and Clinical Urology|March 7, 2019
Microbiome diversity in carriers of fluoroquinolone resistant <i>Escherichia coli</i>Michael A Liss, Robin J Leach, Elizabeth Rourke, et al.
Nature Communications|August 23, 2022
Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNAJonathan C M Wan, Dennis Stephens, Lingqi Luo, et al.
The Journal of Urology|May 27, 2014
Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paperDaniel J Culkin, Emilio J Exaire, David Green, et al.
Prostate Cancer and Prostatic Diseases|July 11, 2018
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapiesKaren S Sfanos, Mark C Markowski, Lauren B Peiffer, et al.
Frontiers in Microbiology|November 9, 2018
Microbiomes Associated With Foods From Plant and Animal SourcesKaren G Jarvis, Ninalynn Daquigan, James R White, et al.
Neoplasia (New York, N.Y.)|July 31, 2022
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)Lauren B Peiffer, James R White, Carli B Jones, et al.
Epilepsy & Behavior : E&B|March 1, 2003
Predictors of postoperative memory function after left anterior temporal lobectomyJames R. White, Debra Matchinsky, Thomas E. Beniak, et al.
BMC Bioinformatics|September 1, 2011
CloVR: a virtual machine for automated and portable sequence analysis from the desktop using cloud computingSamuel V Angiuoli, Malcolm Matalka, Aaron Gussman, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Clinical Pharmacokinetics|July 2, 2009
Characterization of the time course of carbamazepine deinduction by an enzyme turnover modelBaralee Punyawudho, James C Cloyd, Ilo E Leppik, et al.
European Urology Focus|February 18, 2026
Gut Microbiome as a Lifestyle Risk Factor Associated with Prostate CancerMichael A Liss, James R White, Molly Doris, et al.
Investigative and Clinical Urology|March 7, 2019
Microbiome diversity in carriers of fluoroquinolone resistant <i>Escherichia coli</i>Michael A Liss, Robin J Leach, Elizabeth Rourke, et al.
Nature Communications|August 23, 2022
Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNAJonathan C M Wan, Dennis Stephens, Lingqi Luo, et al.
The Journal of Urology|May 27, 2014
Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paperDaniel J Culkin, Emilio J Exaire, David Green, et al.
Prostate Cancer and Prostatic Diseases|July 11, 2018
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapiesKaren S Sfanos, Mark C Markowski, Lauren B Peiffer, et al.
Frontiers in Microbiology|November 9, 2018
Microbiomes Associated With Foods From Plant and Animal SourcesKaren G Jarvis, Ninalynn Daquigan, James R White, et al.
Neoplasia (New York, N.Y.)|July 31, 2022
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)Lauren B Peiffer, James R White, Carli B Jones, et al.
Epilepsy & Behavior : E&B|March 1, 2003
Predictors of postoperative memory function after left anterior temporal lobectomyJames R. White, Debra Matchinsky, Thomas E. Beniak, et al.
BMC Bioinformatics|September 1, 2011
CloVR: a virtual machine for automated and portable sequence analysis from the desktop using cloud computingSamuel V Angiuoli, Malcolm Matalka, Aaron Gussman, et al.
Pageof 14